Rho GDI Antibodies

Santa Cruz Biotechnology delivers a wide array of Rho GDI monoclonal antibodies for research focused on understanding the Rho GTPase signaling pathway. Rho GDI Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Rho GDP-dissociation inhibitor (Rho GDI) plays a crucial role in regulating the activity of Rho GTPases, which are involved in numerous cellular processes such as cytoskeletal dynamics, cell migration, and cell cycle progression. By sequestering Rho GTPases in their inactive GDP-bound form, Rho GDI helps maintain cellular homeostasis and prevent aberrant signaling that can lead to various diseases, including cancer. Understanding the function of Rho GDI is essential for elucidating the mechanisms underlying cellular processes. Researchers can explore the relationship between Rho GDI and various signaling molecules using specific detection methods. Advanced imaging techniques combined with Rho GDI monoclonal antibodies enable visualization of protein localization and interactions within cells. Flow cytometry applications allow for quantitative analysis of Rho GDI expression in different cell populations. Santa Cruz Biotechnology monoclonal antibodies for Rho GDI support researchers worldwide in advancing scientific understanding of cellular signaling mechanisms.